Table 2.
IL-31, CRF, BDNF serum level in psoriatic patients before during and after NB-UVB therapy
IL-31 | CRF | BDNF | |||||||
---|---|---|---|---|---|---|---|---|---|
Baseline | 10 UVB | 20 UVB | Baseline | 10 UVB | 20 UVB | Baseline | 10 UVB | 20 UVB | |
Number of subjets | 59 | 59 | 59 | 59 | 59 | 59 | 59 | 59 | 59 |
Minimum | 22.33 | 89.88 | 57.76 | 0.17 | 0.194 | 0.186 | 1.549 | 6.146 | 4.277 |
25 % Percentile | 608 | 363.5 | 438.6 | 0.334 | 0.321 | 0.363 | 9.789 | 8.777 | 10.72 |
Median level ng/ml | 748.6 | 1112 | 631.7 | 0.426 | 0.426 | 0.449 | 14.15 | 12.82 | 14.15 |
75 % Percentile | 3,153 | 1,920 | 1,595 | 0.7 | 0.69 | 0.705 | 19.29 | 20.76 | 18.68 |
Maximum | 4,853 | 4,419 | 6,009 | 1.173 | 1.145 | 1.08 | 72.94 | 71.75 | 72.7 |
Mean level (ng/ml) | 1,669 | 1,429 | 1,123 | 0.5011 | 0.5099 | 0.5156 | 16.69 | 16.9 | 16.03 |